Home / Industry News / 2010 / Bristol-Myers Squibb to Freeze Salaries in 2010

Bristol-Myers Squibb to Freeze Salaries in 2010

Source: PharmaManufacturing.com

Feb 04, 2010

WSJ.com

Show More Content

More News:

Daiichi Sankyo denies OTC sale rumors

05/23/2019

The Japanese media reported that Daiichi Sankyo was in talks with several companies to sell its over-the-counter drug unit, Daiichi Sankyo Healthcare, but the company has denied the rumors.
Big Pharma partners with tech co. to transform clinical trials

05/22/2019

A group of major pharma companies have teamed up with Verily Life Sciences to overhaul how patients sign up for and engage with clinical trials.
Amgen scoops up biopharma company Nuevolution

05/22/2019

Amgen has reached an agreement to purchase Copenhagen-based Nuevolution AB for about $167 million.
Merck acquires Peloton Therapeutics for $1 billion

05/21/2019

The acquisition of Peloton, which was seeking to go public last week, brings its lead kidney cancer drug candidate to Merck, strengthening its renal cell carcinoma presence
Mallinckrodt sues US health agencies after Medicaid changes

05/21/2019

The makers of Acthar gel has filed a lawsuit against the U.S. Department of Health and Human Services following changes to Medicaid rebate calculations
Supreme Court sides with Merck in landmark decision

05/20/2019

The U.S. Supreme Court gave Merck & Co. a major victory in a case that could be a milestone for further product liability claims.
AbbVie stops trial for brain cancer treatment

05/20/2019

AbbVie is halting a study into a new treatment for glioblastoma.
Takeda, Frazier Healthcare team to launch new biopharma co.

05/20/2019

Takeda and Frazier Healthcare have announced a collaboration to launch Phathom Pharmaceuticals, a biopharmaceutical company focused on novel treatments for gastrointestinal diseases and disorders.
Sandoz announces re-org plan, layoffs

05/20/2019

Sandoz announced a two-stage strategic "transformation" plan, as the company better positions itself for sustainable growth in the generics market.
Novartis could avoid trial with $1B settlement

05/17/2019

Just days before a trial targeting an alleged kickback scheme launched by Novartis is set to begin, there are hints that the company could reach a massive settlement with the U.S. government.

All news

Pharma Manufacturing

Bristol-Myers Squibb to Freeze Salaries in 2010

Supreme Court sides with Merck in landmark decision

The U.S. Supreme Court gave Merck & Co. a major victory in a case that…

Sandoz announces re-org plan, layoffs

Sandoz announced a two-stage strategic "transformation" plan, as the…

Novartis could avoid trial with $1B settlement

Just days before a trial targeting an alleged kickback scheme launched by…

Nestle peaces out of pharma with skincare sale

Nestle has made its last move to exit the pharma industry by selling off…

J&J promises to seek approval for at least 10 new drugs over the next five years

Johnson & Johnson’s pharma unit is slated to take center stage…

Merck to cut jobs, close plants with $1.2B restructuring plan

Merck and Co. has created a restructuring plan it says is designed to…

Torrent hit with Form 483

The FDA found that in hundreds of cases, batches at Torrent’s plant did…

Supreme Court sides with Merck in landmark decision

The U.S. Supreme Court gave Merck & Co. a major victory in a case that…

The biopharma company that’s redefining ‘Made in China’

A leader in biotech explains what it’s like to do business in China,…

Sandoz announces re-org plan, layoffs

Sandoz announced a two-stage strategic "transformation" plan, as the…

Top Pharma Manufacturing Predictions for 2019

From new tech to innovative business models and shifting regulations,…

Top 5 Drugs With the Biggest Growth Potential in 2019

In the coming year, several drugs that treat a range of diseases will far…

Merck to cut jobs, close plants with $1.2B restructuring plan

Merck and Co. has created a restructuring plan it says is designed to…

Torrent hit with Form 483

The FDA found that in hundreds of cases, batches at Torrent’s plant did…

The Highest — and Lowest — Ranked Places to Work in Big Pharma

How pharma companies fair on Glassdoor.